Cargando…
Should glucagon‐like peptide‐1 receptor agonist treatment be withheld in preoperative management?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wiley Publishing Asia Pty Ltd
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509509/ https://www.ncbi.nlm.nih.gov/pubmed/37727016 http://dx.doi.org/10.1111/1753-0407.13469 |
| _version_ | 1785107750243532800 |
|---|---|
| author | Bloomgarden, Zachary |
| author_facet | Bloomgarden, Zachary |
| author_sort | Bloomgarden, Zachary |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10509509 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Wiley Publishing Asia Pty Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105095092023-09-21 Should glucagon‐like peptide‐1 receptor agonist treatment be withheld in preoperative management? Bloomgarden, Zachary J Diabetes Editorial Wiley Publishing Asia Pty Ltd 2023-09-19 /pmc/articles/PMC10509509/ /pubmed/37727016 http://dx.doi.org/10.1111/1753-0407.13469 Text en © 2023 The Author. Journal of Diabetes published by Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Bloomgarden, Zachary Should glucagon‐like peptide‐1 receptor agonist treatment be withheld in preoperative management? |
| title | Should glucagon‐like peptide‐1 receptor agonist treatment be withheld in preoperative management? |
| title_full | Should glucagon‐like peptide‐1 receptor agonist treatment be withheld in preoperative management? |
| title_fullStr | Should glucagon‐like peptide‐1 receptor agonist treatment be withheld in preoperative management? |
| title_full_unstemmed | Should glucagon‐like peptide‐1 receptor agonist treatment be withheld in preoperative management? |
| title_short | Should glucagon‐like peptide‐1 receptor agonist treatment be withheld in preoperative management? |
| title_sort | should glucagon‐like peptide‐1 receptor agonist treatment be withheld in preoperative management? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509509/ https://www.ncbi.nlm.nih.gov/pubmed/37727016 http://dx.doi.org/10.1111/1753-0407.13469 |
| work_keys_str_mv | AT bloomgardenzachary shouldglucagonlikepeptide1receptoragonisttreatmentbewithheldinpreoperativemanagement |